Last reviewed · How we verify

NCT04918654: RND3

Automatic Sound Management 3.0 in a Single-unit Audio Processor

Completed Last updated 21 November 2025
What this trial tests

trial in Cochlear Implants in 20 participants. Completed in 11 December 2023.

Timeline
25 June 2021
Primary endpoint
11 December 2023
11 December 2023

Quick facts

Lead sponsorMED-EL Elektromedizinische Geräte GesmbH
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date25 June 2021
Primary completion11 December 2023
Estimated completion11 December 2023
Sites1 location across Germany

Conditions studied

Sponsor

MED-EL Elektromedizinische Geräte GesmbH — full company profile →

Who can join

18 and older, any sex, with Cochlear Implants. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cochlear implants are routine treatment for people with severe hearing loss. This study tests the RONDO 3, MED-EL's newest single-unit audio processor which comes with new features (Beamformer, Wind-Noise reduction, Ambient noise reduction, Transient noise reduction, Adaptive intelligence).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cochlear Implants

Currently open trials in the same condition.

Other MED-EL Elektromedizinische Geräte GesmbH trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04918654.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing